{"DataElement":{"publicId":"3901772","version":"1","preferredName":"Testicular Cancer American Joint Committee on Cancer (AJCC) Edition 7 Serum Markers Test Result Stage","preferredDefinition":"Stage group determined from information from the serum tumor markers including Alpha Fetoprotein (AFP), Human Chorionic Gonadotropin (hCG) and Lactate Dehydrogenase (LDH).","longName":"3896271v1.0:3896153v1.0","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"3896271","version":"1","preferredName":"Testicular Cancer Serum Markers","preferredDefinition":"A malignant tumor predominantly affecting young men and often associated with cryptorchidism.  Seminoma is the most frequently seen malignant testicular germ cell tumor, followed by embryonal carcinoma and yolk sac tumor. -- 2004_A laboratory test result identifying markers in a blood sample.  It is used in combination with other measures to determine testicular cancer staging.","longName":"2986052v1.0:3896269v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2986052","version":"1","preferredName":"Malignant Testicular Germ Cell Tumor","preferredDefinition":"A malignant tumor predominantly affecting young men and often associated with cryptorchidism.  Seminoma is the most frequently seen malignant testicular germ cell tumor, followed by embryonal carcinoma and yolk sac tumor. -- 2004","longName":"C9063","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Testicular Germ Cell Tumor","conceptCode":"C9063","definition":"A malignant germ cell tumor that arises from the testis. It predominantly affects young men. Seminoma is the most frequently seen malignant testicular germ cell tumor, followed by embryonal carcinoma and yolk sac tumor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7D112249-82D8-E0FD-E040-BB89AD432FCB","latestVersionIndicator":"Yes","beginDate":"2010-01-13","endDate":null,"createdBy":"ZHANGW","dateCreated":"2010-01-13","modifiedBy":"ONEDATA","dateModified":"2010-01-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3896269","version":"1","preferredName":"Testicular Cancer Serum Markers Test Result","preferredDefinition":"A laboratory test result identifying markers in a blood sample.  It is used in combination with other measures to determine testicular cancer staging.","longName":"C111067","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Testicular Cancer Serum Markers Test Result","conceptCode":"C111067","definition":"A laboratory test result in which markers for testicular cancer are tested in a blood sample for staging purposes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E6455C83-1B0A-AB81-E040-BB89AD4365E9","latestVersionIndicator":"Yes","beginDate":"2013-09-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-09-13","modifiedBy":"ONEDATA","dateModified":"2013-09-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E6455C83-1B1B-AB81-E040-BB89AD4365E9","latestVersionIndicator":"Yes","beginDate":"2013-09-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-09-13","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"Created for Testicular Enrollment form per request by T.Lichtenberg. mc 9/13/13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3896153","version":"1","preferredName":"Testicular Cancer American Joint Committee on Cancer Edition 7 Serum Markers Test Result Stage","preferredDefinition":"A finding about one or more characteristics of testicular cancer, following the rules of the TNM AJCC v7 classification system._A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications._A laboratory test result identifying markers in a blood sample.  It is used in combination with other measures to determine testicular cancer staging._The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"3896153v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"2","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"S3","valueDescription":"S3","ValueMeaning":{"publicId":"3896154","version":"1","preferredName":"S3","longName":"3896154","preferredDefinition":"LDH more than 10 × N or hCG (mIu/ml) more than 50,000 or AFP (ng/ml) more than 10,000. N indicates the upper limit of normal for the LDH assay. (AJCC 7th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"S3","conceptCode":"C111072","definition":"LDH more than 10 x N or hCG (mIu/ml) more than 50,000 or AFP (ng/ml) more than 10,000. N indicates the upper limit of normal for the LDH assay. (AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E64364A0-91D2-41BB-E040-BB89AD4328F8","latestVersionIndicator":"Yes","beginDate":"2013-09-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-09-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E64364A0-91EB-41BB-E040-BB89AD4328F8","beginDate":"2013-09-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-09-13","modifiedBy":"ONEDATA","dateModified":"2013-09-13","deletedIndicator":"No"},{"value":"S2","valueDescription":"S2","ValueMeaning":{"publicId":"3896155","version":"1","preferredName":"S2","longName":"3896155","preferredDefinition":"LDH 1.5-10 × N or hCG (mIu/ml) 5,000-50,000 or AFP (ng/ml) 1,000-10,000. N indicates the upper limit of normal for the LDH assay. (AJCC 7th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"S2","conceptCode":"C111071","definition":"LDH 1.5-10 x N or hCG (mIu/ml) 5,000-50,000 or AFP (ng/ml) 1,000-10,000. N indicates the upper limit of normal for the LDH assay. (AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E64364A0-91F7-41BB-E040-BB89AD4328F8","latestVersionIndicator":"Yes","beginDate":"2013-09-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-09-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E64364A0-9210-41BB-E040-BB89AD4328F8","beginDate":"2013-09-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-09-13","modifiedBy":"ONEDATA","dateModified":"2013-09-13","deletedIndicator":"No"},{"value":"S1","valueDescription":"S1","ValueMeaning":{"publicId":"3896156","version":"1","preferredName":"S1","longName":"3896156","preferredDefinition":"LDH less than 1.5 × N and hCG (mIu/ml) less than 5,000 and AFP (ng/ml) less than 1,000.  N indicates the upper limit of normal for the LDH assay. (AJCC 7th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"S1","conceptCode":"C111070","definition":"LDH less than 1.5 x N and hCG (mIu/ml) less than 5,000 and AFP (ng/ml) less than 1,000.  N indicates the upper limit of normal for the LDH assay. (AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E64364A0-921C-41BB-E040-BB89AD4328F8","latestVersionIndicator":"Yes","beginDate":"2013-09-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-09-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E64364A0-9235-41BB-E040-BB89AD4328F8","beginDate":"2013-09-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-09-13","modifiedBy":"ONEDATA","dateModified":"2013-09-13","deletedIndicator":"No"},{"value":"S0","valueDescription":"S0","ValueMeaning":{"publicId":"3896157","version":"1","preferredName":"S0","longName":"3896157","preferredDefinition":"Marker study levels within normal limits. (AJCC 7th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"S0","conceptCode":"C111069","definition":"Marker study levels within normal limits. (AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E64364A0-9241-41BB-E040-BB89AD4328F8","latestVersionIndicator":"Yes","beginDate":"2013-09-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-09-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E64364A0-925A-41BB-E040-BB89AD4328F8","beginDate":"2013-09-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-09-13","modifiedBy":"ONEDATA","dateModified":"2013-09-13","deletedIndicator":"No"},{"value":"SX","valueDescription":"SX","ValueMeaning":{"publicId":"3896158","version":"1","preferredName":"SX","longName":"3896158","preferredDefinition":"Marker studies not available or not performed. (AJCC 7th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"SX","conceptCode":"C111068","definition":"Marker studies not available or not performed. (AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E64364A0-9266-41BB-E040-BB89AD4328F8","latestVersionIndicator":"Yes","beginDate":"2013-09-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-09-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E64364A0-927F-41BB-E040-BB89AD4328F8","beginDate":"2013-09-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-09-13","modifiedBy":"ONEDATA","dateModified":"2013-09-13","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3896152","version":"1","preferredName":"Testicular Cancer TNM Finding v7 American Joint Committee on Cancer Testicular Cancer Serum Markers Test Result Stage","preferredDefinition":"A finding about one or more characteristics of testicular cancer, following the rules of the TNM AJCC v7 classification system.:A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.:A laboratory test result identifying markers in a blood sample.  It is used in combination with other measures to determine testicular cancer staging.:The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"C89236:C39315:C111067:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Testicular Cancer TNM Finding v7","conceptCode":"C89236","definition":"A finding about one or more characteristics of testicular cancer, following the rules of the TNM AJCC v7 classification system.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"American Joint Committee on Cancer","conceptCode":"C39315","definition":"A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Testicular Cancer Serum Markers Test Result","conceptCode":"C111067","definition":"A laboratory test result in which markers for testicular cancer are tested in a blood sample for staging purposes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E64364A0-911C-41BB-E040-BB89AD4328F8","latestVersionIndicator":"Yes","beginDate":"2013-09-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-09-13","modifiedBy":"ONEDATA","dateModified":"2013-09-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E64364A0-912D-41BB-E040-BB89AD4328F8","latestVersionIndicator":"Yes","beginDate":"2013-09-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-09-13","modifiedBy":"COOPERM","dateModified":"2013-09-30","changeDescription":"Created for Testicular Enrollement form per request by T.Lichtenberg. mc 9/12/13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2756809","version":"1","longName":"TCGA (The Cancer Genome Atlas)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6044923","version":"1","longName":"Active CDEs as of March 2017","context":"NCIP"}]},{"publicId":"3461150","version":"1","longName":"Staging","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3461151","version":"1","longName":"AJCC Edition 7","context":"NCIP"}]},{"publicId":"5574838","version":"1","longName":"Staging/Extent of Disease","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"5777529","version":"1","longName":"Testicular","context":"NCI Standards"},{"publicId":"10000596","version":"1","longName":"AJCC Edition 7","context":"NCI Standards"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Serum Tumor Markers (S)","type":"Preferred Question Text","description":"Serum Tumor Markers (S)","url":null,"context":"NCI Standards"},{"name":"AJCC Serum Tumor Markers (S)","type":"Alternate Question Text","description":"AJCC Serum Tumor Markers (S)","url":null,"context":"NCIP"}],"origin":"TCGA:The Cancer Genome Atlas","workflowStatus":"RELEASED","registrationStatus":"Preferred Standard","id":"E6814F69-3352-6A3B-E040-BB89AD4309E6","latestVersionIndicator":"Yes","beginDate":"2013-09-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-09-16","modifiedBy":"TSESU","dateModified":"2018-07-16","changeDescription":"Created for Testicular Enrollment form per request by T.Lichtenberg. mc 9/16/13 Moved to NCI Standards context and Registration Status changed to Preferred Standard. mc 1/31/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}